Somnomed Ltd
ASX:SOM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Somnomed Ltd
Net Issuance of Debt
Somnomed Ltd
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
Net Issuance of Debt
-AU$3.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Net Issuance of Debt
-AU$1.1m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-37%
|
|
|
Cochlear Ltd
ASX:COH
|
Net Issuance of Debt
-AU$23.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
28%
|
CAGR 10-Years
-3%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Net Issuance of Debt
-AU$367.8k
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Net Issuance of Debt
-AU$1.1m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Net Issuance of Debt
-AU$258.9k
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-79%
|
CAGR 10-Years
N/A
|
|
Somnomed Ltd
Glance View
SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. SomnoMed has developed the SomnoDent, a collection of oral devices. SomnoDent includes two product line, such as signature line and standard line. Its signature line products include Herbst Advance Elite, Fusion, Flex and Classic, and standard line products include Herbst Advance, Air/Air+, Morning Repositioner and Alpha. SomnoMed has developed the SomnoBrux, a custom fit acrylic occlusal splint. SomnoBrux product includes Michigan. SomnoMed has developed the SomGauge, is an autoclavable instrument, which can be used to construct accurate and reliable bite records.
See Also
What is Somnomed Ltd's Net Issuance of Debt?
Net Issuance of Debt
-3.5m
AUD
Based on the financial report for Dec 31, 2025, Somnomed Ltd's Net Issuance of Debt amounts to -3.5m AUD.
What is Somnomed Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-2%
Over the last year, the Net Issuance of Debt growth was 76%.
